British journal of clinical practice. Supplement

Owing to the lack of an ideal treatment for endometriosis when fertility must be preserved, there are differences of opinion between those in favour of a mainly surgical approach to therapy, those favouring expectant management of the disea…

The role of the family doctor in the management of endometriosis is considered in three phases. With the exception of a small minority of cases in which there are superficial endometriotic lesions, it will be difficult for the general pract…

Several modalities can be employed in managing the patient with endometriosis, but the ultimate selection is determined by evaluating a number of criteria including age, extent of disease, severity of symptoms and pain. Scoring systems used…

Endometriosis is often debilitating and can adversely affect fertility. Medical management has largely consisted of hormonal therapy, employing the entire spectrum of sex steroids, singly or in combination, and has primarily aimed to reliev…

Endometriosis may be either symptomatic or asymptomatic. Recurrence rates are mostly calculated on the basis of symptomatic patients re-presenting to their doctor. Based on the number of patients who experience recurrence of symptoms after …

In endometriosis, radical surgery to remove both ovaries appears to be the only truly lasting cure. However, to retain or improve fertility potential, conservative surgery to remove all visible endometriotic deposits is often employed. Trad…

Intensive research into endometriosis over the last decade has failed to elucidate its aetiology and pathogenesis. There are uncertainties, too, regarding its diagnosis and management. Trends in endometriosis research in this period are rev…

The uncertainties surrounding the diagnosis and management of endometriosis often leave the patient in pain, feeling confused by the limited information provided by her doctor and with a mixed bag of emotions: fear, grief, anger and self-gu…

A low-dose danazol maintenance therapy (mean total dose 800 mg per month) was given during the luteal phase to 34 women with severe relapsing cyclical mastalgia. On conventional danazol dosage, all subjects had previously obtained a useful …